Korean J Med.  2015 Sep;89(3):265-270. 10.3904/kjm.2015.89.3.265.

Recent Update in Diabetic Nephropathy

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. nhkendo@gmail.com

Abstract

Diabetic nephropathy is the leading cause of end-stage renal disease, and is associated with increased risk of cardiovascular disease. Optimal control of blood glucose and blood pressure based on the blockade of renin-angiotensin system is the standard of care for the prevention and treatment of diabetic nephropathy. Regardless of these therapies, the prevalence of diabetic nephropathy continues to increase, highlighting the need for additional therapies. Diabetes affects the progression of kidney disease through a variety of mechanisms; several new therapeutic agents targeting these pathways have been developed, with currently being evaluated in clinical trials.

Keyword

Diabetic nephropathies; Albuminuria; Renal insufficiency, Chronic; Diagnosis; Therapeutics

MeSH Terms

Albuminuria
Blood Glucose
Blood Pressure
Cardiovascular Diseases
Diabetic Nephropathies*
Diagnosis
Kidney Diseases
Kidney Failure, Chronic
Prevalence
Renal Insufficiency, Chronic
Renin-Angiotensin System
Standard of Care
Blood Glucose
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr